相关实验视频
Updated: Sep 20, 2025

08:32
A Small Animal Model of Ex Vivo Normothermic Liver Perfusion
Published on: June 27, 2018
13.6K
聚乙烯甘) 修改的catalase阻断活性氧物种用于治疗肝脏缺血症
Sai Gao1, Feifei Li1, Dingqi Wu1
1State Key Laboratory of Organic-Inorganic Composites, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
Macromolecular rapid communications
|May 26, 2025
概括
聚乙烯糖醇改性催化酶 (CAT-PEG) 有效降低氧化应激,并改善肝脏功能在肝脏缺血-再输液损伤 (IRI). 这种治疗策略在治疗肝损伤和相关疾病方面表现有前途.
科学领域:
- 生物化学 生化学
- 肝病学 肝病学是一种肝病学.
- 生物医学工程 生物医学工程
背景情况:
- 肝缺血-再损伤 (IRI) 通过氧化应激和炎症导致肝功能障碍.
- 催化酶 (CAT) 分解过氧化,这是氧化损伤的关键媒介.
研究的目的:
- 为了研究聚乙烯糖醇 (PEG) 改性催化酶 (CAT-PEG) 对肝脏IRI的治疗潜力.
- 评估PEGylation对CAT稳定性,生物可用性和疗效的影响.
主要方法:
- 酶被用聚乙烯糖醇 (PEGylation) 修改.
- 在体外和体外模型被用来评估CAT-PEG对氧化应激和肝功能的影响.
- 药理动力学研究评估了PEGylation对CAT半衰期和稳定性的影响.
主要成果:
- 基化增强了CAT的稳定性,并延长了其体内循环半衰期.
- 在肝脏IRI模型中,CAT-PEG显著降低了活性氧物种 (ROS) 水平.
- 用CAT-PEG治疗在再输血后改善了肝功能.
结论:
- 基化甲基酶 (CAT-PEG) 显示出肝脏IRI的显著治疗潜力.
- CAT-PEG有效地减轻氧化损伤并改善肝功能.
- 这种方法对肝移植和其他与氧化压力相关的疾病具有前景.
相关概念视频
Peroxisomes
14.5K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
14.5K
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.4K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.4K

